Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAukett Swanke Regulatory News (AUK)

  • There is currently no data for AUK

Trading Update

4 Nov 2019 07:00

RNS Number : 0483S
Aukett Swanke Group PLC
04 November 2019
 

 

Aukett Swanke Group plc

Trading Update and update regarding Aukett Swanke Moscow

Aukett Swanke Group Plc (the group) ("ASG"), the international group of architects, interior designers and associated engineering is pleased to provide the following trading update on performance to 30 September 2019.

The Board expressed the view that second half trading would be profitable and that this should result in recovering the first half loss to show a positive result at the year end. The Board is now pleased to be able to confirm that this remains the case and that the Group will achieve a profit for the full year to 30 September 2019, subject to there being no material impact for IFRS 9 and 15. Full year results will be reported in January 2020.

At the same time the Board can confirm that year end cash stood at £1,145,000 (2018: £710,000) and after deducting the Long Term Loan used to acquire Shankland Cox, Net Funds stood at £819,000 (2018: £157,000); a satisfactory improvement.

Trading in the new financial year has been stable though we remain vigilant regarding possible adverse impacts as a result the forthcoming General Election and prolonged Brexit negotiations.

Since the year end we have also sold the Group's subsidiary in Moscow, Aukett Swanke OOO ("AS Moscow"), having previously stated the Board's belief that AS Moscow would perform better under local ownership. Under the terms of a Sale Agreement AS Moscow was sold to Maxim Neretin, a Russian national, owner of Aurora Group (another Moscow based architectural practice) with whom the Group has previously co-operated on design projects, for a nominal consideration. The sale will result in inter-company loans being repaid to the Group and, under the terms of a licence arrangement, enables AS Moscow to continue to trade as Aukett Swanke, allowing the Group's brand to endure in this important market. The sale also safeguards our staffs' employment and was achieved without any warranties being provided to the new owner. AS Moscow made a loss of £17,000 in the year to 30 September 2018.

Commenting Nicholas Thompson, CEO, said:

"The recovery from the large loss in 2018 is a tribute to the perseverance of the staff in all of our operations and in the internal rigours of reducing cost during a difficult trading period.

The process to find a suitable successor to carry on the Russian business in our name has taken some considerable time to realise. Critically, the sale has safeguarded the interests of our staff in Moscow, avoids a costly closure process and provides some upside for shareholders through the ongoing licence arrangement. We are pleased with the outcome".

Enquiries

Aukett Swanke group Plc 020 7843 3000

Nicholas Thompson, Chief Executive Officer

Robert Fry, MD International

Tony Barkwith, Group Finance Director

 

finnCap 020 7220 0500

Corporate Finance: Julian Blunt/Giles Rolls

ECM: Alice lane

 

Investor /Media Enquiries 07979 604687

Chris Steele

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFSLFMFFUSELF
Date   Source Headline
23rd Jul 20152:54 pmRNSDirector/PDMR Shareholding
15th Jul 20154:03 pmRNSDirector/PDMR Shareholding
8th Jul 20152:15 pmRNSDirector/PDMR Shareholding
7th Jul 20153:05 pmRNSDirector/PDMR Shareholding
16th Jun 20157:00 amRNSInterim Results
15th Jun 20152:20 pmRNSAcquisition of John R Harris & Partners Limited
26th Mar 201510:35 amRNSResult of AGM
29th Jan 20157:00 amRNSFinal Results
12th Jan 20158:31 amRNSClarification
11th Nov 20147:00 amRNSTrading Update and Dividend Declaration
22nd Aug 20147:00 amRNSDirectorate Change
30th Jun 20147:00 amRNSInterim Results
2nd Jun 20148:05 amRNSDirectorate Change
25th Apr 20147:00 amRNSTrading Statement
3rd Apr 201410:10 amRNSDirector/PDMR Shareholding
31st Mar 20141:34 pmRNSChange of Name
28th Mar 20147:02 amRNSDirectorate Change
25th Mar 20141:12 pmRNSResult of AGM and Change of Name
25th Mar 20147:00 amRNSAGM Statement
5th Mar 20144:37 pmRNSHolding(s) in Company
3rd Mar 20145:20 pmRNSDirector/PDMR Shareholding
25th Feb 20149:13 amRNSAnnual Financial Report
20th Jan 20147:00 amRNSAnnual Financial Report
15th Jan 20149:29 amRNSTotal Voting Rights
19th Dec 20137:00 amRNSAcquisition of Swanke Hayden Connell Europe Ltd
10th Dec 20137:00 amRNSDirectorate Change
2nd Dec 20137:00 amRNSTrading Update
8th Nov 20137:00 amRNSDividend Declaration
1st Oct 20137:00 amRNSTrading Update
12th Aug 20137:00 amRNSTrading Statement
7th Jun 20137:00 amRNSHalf Yearly Report
25th Mar 20132:45 pmRNSResult of AGM
13th Mar 201310:22 amRNSLitigation and Trading Update
27th Feb 20132:52 pmRNSAnnual Financial Report
30th Jan 20137:00 amRNSFinal Results
19th Jul 20123:08 pmRNSHalf Yearly Report
27th Jun 201211:31 amRNSDirector/PDMR Shareholding
7th Jun 20127:00 amRNSHalf Yearly Report
31st May 20127:00 amRNSNotice of Interim Results
27th Mar 20125:53 pmRNSResult of AGM and change of directorate
15th Feb 201212:06 pmRNSAnnual Financial Report
12th Jan 20127:00 amRNSFinal Results
18th Oct 20118:27 amRNSDirector/PDMR Shareholding
20th Sep 20117:00 amRNSTrading update
1st Jul 20117:00 amRNSLitigation update
21st Jun 20117:00 amRNSHalf Yearly Report
12th Apr 20119:26 amRNSDirector/PDMR Shareholding
7th Apr 201111:21 amRNSTrading update
31st Mar 201112:55 pmRNSResult of AGM
25th Feb 20119:37 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.